preferred anti angiogenesis agents include sunitinib sutenttm bevacizumab (Pfizer Inc)
86
Structured Review
Pfizer Inc
preferred anti angiogenesis agents include sunitinib sutenttm bevacizumab
Preferred Anti Angiogenesis Agents Include Sunitinib Sutenttm Bevacizumab, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sunitinib+sutenttm/anti+avelumab/us12447153-758-0-13
Average 86 stars, based on 1 article reviews
Preferred Anti Angiogenesis Agents Include Sunitinib Sutenttm Bevacizumab, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sunitinib+sutenttm/anti+avelumab/us12447153-758-0-13
Average 86 stars, based on 1 article reviews
preferred anti angiogenesis agents include sunitinib sutenttm bevacizumab - by Bioz Stars,
2026-09
86/100 stars
Images
Related Articles
Clinical Proteomics:Article Title: Renal cell carcinoma metastasis to the thyroid gland: a case report. Article Snippet: The patient got six cycles of Article Title: Synthesis and Biophysical Insights into the Binding of a Potent Anti-Proliferative Non-symmetric Bis-isatin Derivative with Bovine Serum Albumin: Spectroscopic and Molecular Docking Approaches Article Snippet: A representative example of an already developed isatin-based anticancer drug is Article Title: Target therapies in recurrent or metastatic head and neck cancer: state of the art and novel perspectives. A systematic review. Article Snippet: 4.3 Article Title: Anti-galectin antibody biomarkers predictive of anti-immune checkpoint and anti-angiogenesis responses Article Snippet: These drugs such as Article Title: Dose and schedule modification are required for long-term continuation of sunitinib in Japanese patients with advanced pancreatic neuroendocrine tumors. Article Snippet: Purpose This study aimed to clarify the efficacy and safety of sunitinib in Japanese patients with pancreatic neuroendocrine tumors (PNET), especially by focusing on dose and schedule modification.. Methods Sixteen patients with advanced PNET treated with sunitinib were reviewed retrospectively.. Efficacy was evaluated by progression-free survival (PFS) and objective tumor response. Article Title: Investigational drugs for nasopharyngeal carcinoma. Article Snippet: Introduction: Nasopharyngeal carcinoma (NPC) is endemic to Southern China and Asia and is etiologically associated with the Epstein Barr virus (EBV).. Whole exome and genome sequencing (WES, WGS) studies of NPC have reported several actionable therapeutic targets, and that the mutational load of NPC maybe comparable to that of squamous head and neck cancer.. These unique biological characteristics have been exploited as potential targets and a wide range of investigational drugs are being investigated in clinical trials. Article Title: Pyrido[4,3-d]pyrimidine compounds Article Snippet: Preferred anti-angiogenesis agents include sunitinib (SutentTM), bevacizumab (AvastinTM), axitinib (InlytaTM), Article Title: Toll-like receptor agonists Article Snippet: Preferred anti-angiogenesis agents include sunitinib (SutentTM), bevacizumab (AvastinTM), Activity Assay:Article Title: Renal cell carcinoma metastasis to the thyroid gland: a case report. Article Snippet: The patient got six cycles of Article Title: Synthesis and Biophysical Insights into the Binding of a Potent Anti-Proliferative Non-symmetric Bis-isatin Derivative with Bovine Serum Albumin: Spectroscopic and Molecular Docking Approaches Article Snippet: A representative example of an already developed isatin-based anticancer drug is Article Title: Target therapies in recurrent or metastatic head and neck cancer: state of the art and novel perspectives. A systematic review. Article Snippet: 4.3 Article Title: Anti-galectin antibody biomarkers predictive of anti-immune checkpoint and anti-angiogenesis responses Article Snippet: These drugs such as Article Title: Dose and schedule modification are required for long-term continuation of sunitinib in Japanese patients with advanced pancreatic neuroendocrine tumors. Article Snippet: Purpose This study aimed to clarify the efficacy and safety of sunitinib in Japanese patients with pancreatic neuroendocrine tumors (PNET), especially by focusing on dose and schedule modification.. Methods Sixteen patients with advanced PNET treated with sunitinib were reviewed retrospectively.. Efficacy was evaluated by progression-free survival (PFS) and objective tumor response. Article Title: Investigational drugs for nasopharyngeal carcinoma. Article Snippet: Introduction: Nasopharyngeal carcinoma (NPC) is endemic to Southern China and Asia and is etiologically associated with the Epstein Barr virus (EBV).. Whole exome and genome sequencing (WES, WGS) studies of NPC have reported several actionable therapeutic targets, and that the mutational load of NPC maybe comparable to that of squamous head and neck cancer.. These unique biological characteristics have been exploited as potential targets and a wide range of investigational drugs are being investigated in clinical trials. Article Title: Pyrido[4,3-d]pyrimidine compounds Article Snippet: Preferred anti-angiogenesis agents include sunitinib (SutentTM), bevacizumab (AvastinTM), axitinib (InlytaTM), Article Title: Toll-like receptor agonists Article Snippet: Preferred anti-angiogenesis agents include sunitinib (SutentTM), bevacizumab (AvastinTM), |